🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationState pharmacy board compounding enforcement actions — looking for input Page 7

State pharmacy board compounding enforcement actions — looking for input

TomTeleRx Sun, Jan 4, 2026 at 8:18 AM 34 replies 1,751 viewsPage 7 of 7
SleepFixSam
Member
212
678
Nov 2024
Hawaii
Jan 8, 2026 at 8:24 AM#31
labquiet_amy said:
I have been on both brand and compounded, and in the context of compounded supply, my experience has been equivalent with both.

Compounding pharmacy customer here with experience relevant to compounded supply.

I've ordered from 4 different compounding pharmacies over the past 14 months. The quality variation is real — purity ranged from 94% to 101% of label claim based on independent Janoshik testing.

My current compounder (a 503B facility) has been consistently 98-101% purity across 8 orders. I pay $155/month vs $1,265 for brand. The savings are substantial and the product is equivalent in my experience.

Re: compounded supply — this applies whether you're using brand or compounded. The clinical principles are the same.

Last edited: Jan 8, 2026 at 10:24 AM
18 18pete_nash, hank_denver, carlos_SATX and 15 others
Reply Quote Save Share Report
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Jan 8, 2026 at 3:10 PM#32
labquiet_amy said:
I have been on both brand and compounded, and in the context of compounded supply, my experience has been equivalent with both.

Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.

17 17maya_sedona, stefan_berlin, Dr.EM_Chicago and 14 others
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Jan 8, 2026 at 9:56 PM#33

Adding the clinical framing, because it changes how the question reads.

503A vs 503B compounding pharmacies for compounded supply — this distinction matters enormously:

Feature503A503B
RegulationState Board of PharmacyFDA-registered
PrescriptionRequired (patient-specific)Can compound without patient Rx
TestingVaries by statecGMP required
ScaleSmall batchesLarger production
Quality consistencyVariableGenerally higher

I strongly recommend 503B facilities. The FDA oversight and cGMP requirements mean more consistent product quality.

16 16adam_van, Dr.SurgeonPGH, rachel_ABQ and 13 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Jan 9, 2026 at 4:42 AM#34
Dr.SportsMedIN said:
503A vs 503B compounding pharmacies for compounded supply — this distinction matters enormously: Feature 503A 503B Regulation State Board of Pharmacy…

This matches mine closely enough to be worth saying so out loud. I had assumed I was the exception until I read this.

15 15lucas_SP_BR, lisa_labSD, adam_van and 12 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Jan 9, 2026 at 11:28 AM#35
Dr.SportsMedIN said:
503A vs 503B compounding pharmacies for compounded supply — this distinction matters enormously: Feature 503A 503B Regulation State Board of Pharmacy…

Coming at Dr.SportsMedIN’s question from a different direction. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

14 14JessicaM_2024, TomFromTexas, mike.trainer_LA and 11 others
Reply Quote Save Share Report
1567

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register